AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Tricyclic Antidepressants as a Second-Line Treatment for IBSD
Discussion on a trial investigating the use of tricyclic antidepressants as a second-line treatment for IBSD, covering patient selection, side effects, first-line therapies, trial results, depression's impact on treatment, and the potential benefits of TCAs as a neuromodulator.